Abstract
Due to donor shortage, patients with refractory heart failure need to be supported on mechanical circulatory support (MCS). Critically, patients undergo several deployments of MCS in stages inevitably requiring blood products transfusion. MCSs per se along with blood products can trigger immune allosensitization. Antibody-mediated rejection (AMR) is associated with significant mortality after heart transplantation. Here, we present the case with high panel-reactive antibody over 95% who developed AMR early after heart transplantation. This life-threatening complication was successfully treated with multi-modal treatment including anti-CD20 antibody, rituximab.
Similar content being viewed by others
References
Reed EF, Demetris AJ, Hammond E, Itescu S, Kobashigawa JA, Reinsmoen NL, et al. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant. 2006;25:153–59.
Michaels P, Espejo M, Kobashigawa J, Alejos J, Burch C, Takemoto S, et al. Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant. 2003;22:58–69.
Hammond EH, Wittwer CT, Greenwood J, Knape WA, Yowell RL, Menlove RL, et al. Relationship of OKT3 sensitization and vascular rejection in cardiac transplant patients receiving OKT3 rejection prophylaxis. Transplantation. 1990;50:776–82.
Rodriguez E, Skojec D, Tan C, Zachary A, Kasper E, Conte J, et al. Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers. Am J Transplant. 2005;5:2778–85.
Saito S, Matsumiya G, Fukushima N, Sakaguchi T, Fujita T, Ueno T, et al. Successful treatment of cardiogenic shock caused by humoral cardiac allograft rejection. Circ J. 2009;73:970–3.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
We have no conflict of interest to disclose.
Rights and permissions
About this article
Cite this article
Akiyama, M., Takahara, S., Kawatsu, S. et al. Successful management of antibody-mediated rejection after cardiac transplantation in a patient supported by a left ventricular assist device for more than 3 years. Gen Thorac Cardiovasc Surg 65, 710–712 (2017). https://doi.org/10.1007/s11748-017-0763-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-017-0763-3